The Prognostic Role of Ribosomal Protein S6 Kinase 1 Pathway in Patients With Solid Tumors: A Meta-Analysis
Author:
Funder
National Natural Science Foundation of China
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference80 articles.
1. Cancer statistics, 2015;Siegel;CA Cancer J Clin.,2015
2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin.,2016
3. The cost and burden of cancer in the European Union 1995–2014;Jonsson;Eur J Cancer.,2016
4. Recent advances in “smart” delivery systems for extended drug release in cancer therapy;Kalaydina;Int J Nanomed.,2018
5. Systemic treatment of metastatic clear cell renal cell carcinoma in 2018: current paradigms, use of immunotherapy, and future directions;Lalani;Eur Urol.,2018
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Expression of PD-L1 and p-RPS6 in epithelial dysplasia and squamous cell carcinoma of the oral cavity;Frontiers in Oral Health;2024-02-02
2. Activation of the Akt signalling pathway as a prognostic indicator in canine soft tissue sarcoma;Journal of Comparative Pathology;2023-10
3. Expression of Ribosomal Protein S6 Kinase (S6K1) Isoforms in Different Types of Papillary Thyroid Carcinoma;Cytology and Genetics;2023-07-27
4. PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2− BC patients with residual disease after neoadjuvant chemotherapy: a cohort study;Journal of Clinical Pathology;2023-06-21
5. p70 S6 kinase as a therapeutic target in cancers: More than just an mTOR effector;Cancer Letters;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3